Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1

2(28.6%)

N/A

2(28.6%)

Phase 3

2(28.6%)

Phase 2

1(14.3%)

7Total

Phase 1(2)

N/A(2)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00562302Phase 3Completed

Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure

Role: lead

NCT01033357Not ApplicableTerminated

Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

Role: lead

NCT00288418Phase 3Completed

Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization

Role: lead

NCT00677222Phase 1Completed

Safety Study of AMI MultiStem® to Treat Heart Attacks

Role: collaborator

NCT00448708Not ApplicableTerminated

Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

Role: lead

NCT00055133Phase 2Completed

A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis

Role: lead

NCT00562471Phase 1Completed

Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation

Role: lead

All 7 trials loaded